litlas
ログインアカウント作成

Paul M. Harari

1990–2025 年に発表

95
論文数
22,324
被引用数
71
h 指数
90
i10 指数

被引用数

Paul M. Harari の年別被引用数1991 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 4 件1996 年: 被引用 2 件1997 年: 被引用 4 件1998 年: 被引用 6 件1999 年: 被引用 10 件2000 年: 被引用 30 件2001 年: 被引用 58 件2002 年: 被引用 58 件2003 年: 被引用 77 件2004 年: 被引用 87 件2005 年: 被引用 149 件2006 年: 被引用 155 件2007 年: 被引用 215 件2008 年: 被引用 189 件2009 年: 被引用 195 件2010 年: 被引用 207 件2011 年: 被引用 186 件2012 年: 被引用 156 件2013 年: 被引用 187 件2014 年: 被引用 175 件2015 年: 被引用 153 件2016 年: 被引用 133 件2017 年: 被引用 124 件2018 年: 被引用 84 件2019 年: 被引用 589 件2020 年: 被引用 642 件2021 年: 被引用 574 件2022 年: 被引用 418 件2023 年: 被引用 293 件2024 年: 被引用 416 件2025 年: 被引用 233 件2026 年: 被引用 7 件1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,213 件、この内訳の 31.7%中国: 引用元論文 527 件、この内訳の 7.6%ドイツ: 引用元論文 419 件、この内訳の 6%イギリス: 引用元論文 355 件、この内訳の 5.1%イタリア: 引用元論文 314 件、この内訳の 4.5%カナダ: 引用元論文 268 件、この内訳の 3.9%オランダ: 引用元論文 261 件、この内訳の 3.7%フランス: 引用元論文 259 件、この内訳の 3.7%日本: 引用元論文 183 件、この内訳の 2.6%スペイン: 引用元論文 176 件、この内訳の 2.5%オーストラリア: 引用元論文 169 件、この内訳の 2.4%ベルギー: 引用元論文 168 件、この内訳の 2.4%
0%31.7%その他 23.9%

機関

分野

  • Medicine69%
  • Biochemistry, Genetics and Molecular Biology16.4%
  • Physics and Astronomy6.1%
  • Engineering2.2%
  • Immunology and Microbiology2.1%
  • Computer Science1.1%
  • その他3.1%

トピック

  • Head and Neck Cancer Studies10.3%
  • Lung Cancer Treatments and Mutations4.7%
  • HER2/EGFR in Cancer Research3.9%
  • Advanced Radiotherapy Techniques3.5%
  • Esophageal Cancer Research and Treatment2.4%
  • Cancer Immunotherapy and Biomarkers2.4%
  • その他72.8%

共著者

全論文

検索で開く
  1. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

    著者: Maura L. Gillison, Andy Trotti, Jonathan Harris, Avraham Eisbruch, Paul M. Harari, David J. Adelstein, Richard C. Jordan, Weiqiang Zhao, Erich M. Sturgis, Barbara Burtness, John A. Ridge, Jolie Ringash, James M. Galvin, Min Yao, Shlomo A. Koyfman, Dukagjin Blakaj, Mohammed A. Razaq, A. Dimitrios Colevas, Jonathan J. Beitler, Christopher U. Jones, Neal Dunlap, Samantha A. Seaward, Sharon A. Spencer, Thomas J. Galloway, Jack Phan, James J. Dignam, Quynh‐Thu Le - The Lancet 2018 被引用: 1,295

  2. Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

    著者: James A. Bonner, Paul M. Harari, J. Giralt, N. Azarnia, Dong M. Shin, Roger B. Cohen, Christopher U. Jones, Ranjan Sur, David Raben, Jacek Jassem, Roger Ove, Merrill S. Kies, José Baselga, Hagop Youssoufian, Nadia Amellal, Eric K. Rowinsky, K. Kian Ang - New England Journal of Medicine 2006 被引用: 5,106

  3. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

    著者: James A. Bonner, Paul M. Harari, J. Giralt, Roger B. Cohen, Christopher U. Jones, Ranjan Sur, David Raben, José Baselga, Sharon A. Spencer, Junming Zhu, Hagop Youssoufian, Eric K. Rowinsky, K. Kian Ang - The Lancet Oncology 2009 被引用: 1,974

  4. Fragmentomic analysis of circulating tumor DNA-targeted cancer panels

    著者: Kyle T. Helzer, Marina N. Sharifi, Jamie M. Sperger, Yue Shi, Matti Annala, Matthew L. Bootsma, Steve Reese, Amy K. Taylor, Katherine R. Kaufmann, Hannah Krause, Jennifer L. Schehr, N. Sethakorn, David Kosoff, Christos E. Kyriakopoulos, Mark E. Burkard, Nicholas R. Rydzewski, Menggang Yu, Paul M. Harari, M. Bassetti, Grace C. Blitzer, John M. Floberg, Martin Sjöström, David A. Quigley, Scott M. Dehm, Andrew J. Armstrong, Himisha Beltran, Rana R. McKay, Felix Y. Feng, Ruth O’Regan, Kari B. Wisinski, Hamid Emamekhoo, Alexander W. Wyatt, Joshua M. Lang, Shuang G. Zhao - Annals of Oncology 2023 被引用: 65

  5. In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments

    著者: Zachary S. Morris, Emily I. Guy, David M. Francis, Monica M. Gressett, Lauryn R. Werner, Lakeesha Carmichael, Richard K. Yang, Eric A. Armstrong, Shyhmin Huang, Fariba Navid, Stephen D. Gillies, Alan J. Korman, Jacquelyn A. Hank, Alexander L. Rakhmilevich, Paul M. Harari, Paul M. Sondel - Cancer Research 2016 被引用: 156

  6. Understanding resistance to EGFR inhibitors—impact on future treatment strategies

    著者: Deric L. Wheeler, Emily Dunn, Paul M. Harari - Nature Reviews Clinical Oncology 2010 被引用: 694

  7. The Promise of Combining Radiation Therapy With Immunotherapy

    著者: Justin C. Jagodinsky, Paul M. Harari, Zachary S. Morris - International Journal of Radiation Oncology*Biology*Physics 2020 被引用: 148

  8. Targeting AKT/PKB to improve treatment outcomes for solid tumors

    著者: Mari Iida, Paul M. Harari, Deric L. Wheeler, Mahmoud Toulany - Mutation research. Fundamental and molecular mechanisms of mutagenesis 2020 被引用: 76

  9. Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer

    著者: Randall J. Kimple, Molly A. Smith, Grace C. Blitzer, Alexandra D. Torres, Joshua A. Martin, Robert Yang, Chimera R. Peet, Laurel D. Lorenz, Kwangok P. Nickel, Aloysius J. Klingelhutz, Paul F. Lambert, Paul M. Harari - Cancer Research 2013 被引用: 373

  10. Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)

    著者: Jérôme Fayette, Lori J. Wirth, Cristina Oprean, Anghel Adrian Udrea, Antonio Jimeno, Danny Rischin, Christopher M. Nutting, Paul M. Harari, Tibor Csőszi, Dana Cernea, Paul E. O’Brien, William D. Hanley, Amy V. Kapp, Maria Anderson, Elicia Penuel, Bruce McCall, Andrea Pirzkall, Jan B. Vermorken - Frontiers in Oncology 2016 被引用: 106

  11. Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade

    著者: Justin C. Jagodinsky, Jessica M. Vera, Won Jong Jin, Amanda G. Shea, Paul A. Clark, Raghava N. Sriramaneni, Thomas C. Havighurst, Ishan Chakravarthy, Raad H. Allawi, KyungMann Kim, Paul M. Harari, Paul M. Sondel, Michael A. Newton, Marka R. Crittenden, Michael J. Gough, Jessica R. Miller, Irene M. Ong, Zachary S. Morris - Science Translational Medicine 2024 被引用: 63

  12. Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function

    著者: Max M. Gong, Karina M. Lugo-Cintrón, Bridget R. White, Sheena C. Kerr, Paul M. Harari, David J. Beebe - Biomaterials 2019 被引用: 86

  13. Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology

    著者: Robert G. Bristow, Brian M. Alexander, Michaël Baumann, Scott V. Bratman, J. Martin Brown, Kevin Camphausen, Peter L. Choyke, Deborah E. Citrin, Joseph N. Contessa, Adam P. Dicker, David G. Kirsch, Mechthild Krause, Quynh‐Thu Le, Michael Milosevic, Zachary S. Morris, Jann N. Sarkaria, Paul M. Sondel, Phuoc T. Tran, George D. Wilson, Henning Willers, Rebecca Wong, Paul M. Harari - The Lancet Oncology 2018 被引用: 120

  14. Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma

    著者: Matthew L. Bootsma, Rana R. McKay, Hamid Emamekhoo, Rory M. Bade, Jennifer L. Schehr, Matthew C. Mannino, Anupama Singh, Serena K. Wolfe, Zachery D. Schultz, Jamie M. Sperger, Wanling Xie, Sabina Signoretti, Christos E. Kyriakopoulos, David Kosoff, E. Jason Abel, Kyle T. Helzer, Nicholas R. Rydzewski, Hamza Bakhtiar, Yue Shi, Grace C. Blitzer, Michael Bassetti, John M. Floberg, Menggang Yu, Nan Sethakorn, Marina N. Sharifi, Paul M. Harari, Toni K. Choueiri, Joshua M. Lang, Shuang G. Zhao - Journal of Clinical Oncology 2022 被引用: 28

  15. Epidermal growth factor receptor inhibition strategies in oncology

    著者: Paul M. Harari - Endocrine Related Cancer 2004 被引用: 422

  16. Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22)

    著者: Avraham Eisbruch, Jonathan Harris, Adam S. Garden, C. Chao, William L. Straube, Paul M. Harari, Giuseppe Sanguineti, Christopher U. Jones, Walter Bosch, K. Kian Ang - International Journal of Radiation Oncology*Biology*Physics 2009 被引用: 377

  17. Heterogeneity in head and neck IMRT target design and clinical practice

    著者: Theodore S. Hong, Wolfgang A. Tomé, Paul M. Harari - Radiotherapy and Oncology 2012 被引用: 154

  18. Microphysiological head and neck cancer model identifies novel role of lymphatically secreted monocyte migration inhibitory factor in cancer cell migration and metabolism

    著者: Ravi Chandra Yada, Danielle E. Desa, Amani A. Gillette, Emmett Bartels, Paul M. Harari, Melissa C. Skala, David J. Beebe, Sheena C. Kerr - Biomaterials 2023 被引用: 24

  19. p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma

    著者: Christine H. Chung, Qiang Zhang, Christina S. Kong, Jonathan Harris, Elana J. Fertig, Paul M. Harari, Dian Wang, Kevin P. Redmond, George Shenouda, Andy Trotti, David Raben, Maura L. Gillison, Richard C. Jordan, Quynh‐Thu Le - Journal of Clinical Oncology 2014 被引用: 377

  20. Human Tumor‐Lymphatic Microfluidic Model Reveals Differential Conditioning of Lymphatic Vessels by Breast Cancer Cells

    著者: José M. Ayuso, Max M. Gong, Melissa C. Skala, Paul M. Harari, David J. Beebe - Advanced Healthcare Materials 2020 被引用: 71

  21. A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer

    著者: Shuang G. Zhao, Jamie M. Sperger, Jennifer L. Schehr, Rana R. McKay, Hamid Emamekhoo, Anupama Singh, Zachery D. Schultz, Rory M. Bade, Charlotte N. Stahlfeld, Cole S. Gilsdorf, Camila I. Hernandez, Serena K. Wolfe, Richel D. Mayberry, Hannah M. Krause, Matt Bootsma, Kyle T. Helzer, Nicholas R. Rydzewski, Hamza Bakhtiar, Yue Shi, Grace C. Blitzer, Christos E. Kyriakopoulos, David Kosoff, Xiao X. Wei, John M. Floberg, Nan Sethakorn, Marina N. Sharifi, Paul M. Harari, Wei Huang, Himisha Beltran, Toni K. Choueiri, Howard I. Scher, Dana E. Rathkopf, Susan Halabi, Andrew J. Armstrong, David J. Beebe, Menggang Yu, Kaitlin E. Sundling, Mary‐Ellen Taplin, Joshua M. Lang - Journal of Clinical Investigation 2022 被引用: 33

  22. Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

    著者: Deric L. Wheeler, Shih‐Hao Huang, Tim J. Kruser, Meghan Nechrebecki, Eric A. Armstrong, Sergi Benavente, Vinai Gondi, K-T Hsu, Paul M. Harari - Oncogene 2008 被引用: 549

  23. Mechanisms of Enhanced Radiation Response following Epidermal Growth Factor Receptor Signaling Inhibition by Erlotinib (Tarceva)

    著者: Prakash Chinnaiyan, Shyhmin Huang, Geetha D. Vallabhaneni, Eric A. Armstrong, Sooryanarayana Varambally, Scott A. Tomlins, Arul M. Chinnaiyan, Paul M. Harari - Cancer Research 2005 被引用: 387

  24. Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)

    著者: Vasu Divi, Jonathan Harris, Paul M. Harari, Jay S. Cooper, Jonathan B. McHugh, Diana Bell, Erich M. Sturgis, Anthony J. Cmelak, Mohan Suntharalingam, David Raben, Harold Kim, Sharon A. Spencer, George E. Laramore, Andy Trotti, Robert L. Foote, Christopher J. Schultz, Wade L. Thorstad, Qiang Zhang, Quynh‐Thu Le, F. Christopher Holsinger - Cancer 2016 被引用: 104